In parenteral drug delivery, syringeability and injectability are often treated as if they mean the same thing. They do not.
What Is Syringeability?
Syringeability refers to the ease with which a drug formulation can be withdrawn from its container into a syringe and prepared in a practical, reliable way. It is influenced by factors such as ease of withdrawal, clogging or foaming tendencies, and the ability to measure and prepare the intended dose accurately.
What Is Injectability?
Injectability is broader and encompasses syringeability. It asks whether that same product can actually be administered in a practical, clinically usable way under real conditions. That includes factors such as the pressure or force required during injection, the evenness of flow, the needle being used, the route of administration, and dose preparation and administration ergonomics.
That distinction matters because a formulation can appear acceptable based on viscosity, flow behavior, or bench syringe-and-needle testing, yet still create problems at the point of administration.
This is especially important in ophthalmology, where intravitreal drugs are administered through very fine needles, commonly 30-gauge and 33-gauge, making small formulation differences more consequential in use.
Bradford Sullivan, PhD
Vice-President & Co-Founder
Callan Pharma Services
What Matters During Formulation Development?
1. Viscosity is important, but it is not the whole story.
Viscosity is often one of the first things evaluated when developing a formulation that is both syringeable and injectable. But lower viscosity alone does not guarantee better performance.
What matters is how the formulation behaves through the intended syringe-and-needle system under use-relevant conditions. A formulation can look acceptable based on bulk viscosity and still create delivery problems once pressure, flow, and needle size are taken into account.
2. Particle size and microstructure both matter.
A formulation does not have to be highly viscous to create injection problems. Fine particles, droplets, gelation, or other structural features can still interfere with smooth delivery if they are not well controlled.
Even when the average particle size looks acceptable, aggregation, phase changes, or an unstable dispersion can make performance less predictable during withdrawal or injection. In practice, what matters is not just size, but whether the formulation maintains a consistent, well-behaved structure throughout handling and administration.
3. Processing method can change syringeability and injectability.
Formulation technique can be just as important as composition. Mixing conditions, shear, temperature, energy input, and order of addition can all change viscosity, dispersion state, and flow behavior.
As a result, two formulations with the same composition can still perform very differently during withdrawal or injection. That is why syringeability and injectability should be evaluated in the context of both formulation composition and processing method.
4. Concentration and dose volume create tradeoffs.
Higher drug concentration can be attractive because it may allow smaller injection volumes, but it often makes syringeability and injectability more difficult. As drug and excipient concentrations increase, formulations may become more viscous, less stable, or harder to deliver consistently through the intended needle system.
Dose volume creates its own constraints, especially in routes where only limited volume can be administered comfortably or practically, such as intravitreal injection. In formulation development, the challenge is not just hitting the target dose, but doing so in a way that still supports reliable preparation and administration.
5. Stability can change performance over time.
A formulation may be syringeable and injectable when it is first prepared, but that does not guarantee it will behave the same way over time. Storage, temperature changes, handling, and normal aging can all affect viscosity, dispersion state, and flow behavior.
As a result, a formulation that performs well early on may later become harder to withdraw, harder to inject, or more prone to clogging. That is why syringeability and injectability should be considered not just at time zero, but across the formulation’s expected storage and use conditions.
The Practical Takeaway
From a drug development standpoint, the goal is not simply to create a formulation that can be filled into a syringe. The goal is to create one that can still be prepared, delivered, and used reliably under real conditions, including after storage. That is why syringeability and injectability are worth thinking about early, before they become late-stage problems.
If syringeability or injectability is shaping your program, let’s talk.
Frequently Asked Questions
What is the difference between syringeability and injectability?
Syringeability is the ease of withdrawing a formulation from its container into a syringe and preparing an accurate dose. Injectability is broader and includes syringeability: it also covers whether the product can be administered practically under real clinical conditions, accounting for injection force, flow evenness, needle gauge, and route of administration. A formulation can be syringeable but still difficult to inject.
Does low viscosity guarantee good injectability?
No. Viscosity is important, but it is not the whole story. Particle size, microstructure, dispersion stability, processing method, needle gauge, and dose volume all affect how a formulation performs through the intended syringe-and-needle system. A formulation can look acceptable on bulk viscosity and still create delivery problems in use.
Why does needle gauge matter for intravitreal injection?
Intravitreal drugs are administered through very fine needles, commonly 30-gauge or 33-gauge. At those diameters, small formulation differences in viscosity, particle size, or dispersion state become much more consequential, so syringeability and injectability must be evaluated against the specific needle system intended for use.
